What is at stake
Since 2017, when Nike launched the Vaporfly, elite running has moved to a new level. World records that seemed untouchable fell one after another. At the center of this acceleration is a combination of two ingredients: a rigid carbon fiber plate embedded in the midsole and a light foam with very high energy return (typically PEBA-derived). The criticism is direct: if the shoe returns energy the runner did not spend, is that not a form of technological doping, capable of invalidating the comparison with old marks?
The question is legitimate and deserves an evidence-based answer, not an opinion. Let us separate what the best science shows from what is just noise.
The accusers' side
Those who argue there was a break of equity have concrete arguments. The gain is measurable and systematic, not a matter of the athlete feeling better. Beyond that, the technology arrived unevenly: for a period, runners sponsored by a single brand had access to prototypes nobody else could buy. That created an advantage of equipment, not of training or talent.
There is also the problem of historical comparison. Paula Radcliffe's women's marathon record (2:15:25, from 2003) stood for 16 years, until 2019. After super shoes arrived, the barrier plummeted again. Comparing a time from 2010 with one from 2024 became comparing two races run with fundamentally different equipment.
The defenders' side
On the other side, the argument is that footwear has always been technology. Nobody asks runners to go back to competing barefoot or in 1970s canvas shoes. The evolution of materials is a legitimate part of sport, the same way it happened with bikes, rackets and swimming suits. As long as the rule is the same for everyone and the product is on sale in the market, there is no individual cheating: the athlete is hiding nothing and circumventing no anti-doping control.
The central point of this defense is that the super shoe does not run for the athlete. It reduces the metabolic cost of holding a pace, but the runner still needs to generate the power, sustain the pace and endure 42 kilometers. The benefit is real, yet accessible and transparent.
What the best evidence says
Here the science is surprisingly clear and convergent. The study that named the category measured that the Vaporfly improved running economy by about 4% on average, with all 18 participants showing a gain.
One percent in an elite marathon is not small: it is more than a minute for a 2h runner. That gain helps explain why historic marks were beaten in sequence and why the marathon sub-2h probably would not have happened at the pace it did without this technology. It is worth noting that the benefit is not universal: on steep climbs, some studies show the metabolic cost even increases with the plate. The gain is large on flat, consistent ground, the exact scenario of the road marathon.
How World Athletics responded
The international federation did not ban super shoes. In 2020, it regulated them. The three main locks are simple to understand:
- Maximum midsole thickness: 40 mm for road shoes (lower limit for spiked track races).
- One plate only: the shoe cannot contain more than one embedded rigid plate.
- Commercial availability: the model must be on sale at retail for at least four months before being used in competition, which in practice prohibits secret prototypes.
The availability rule was the direct response to the equity problem: if everyone can buy, nobody has a hidden advantage. The manufacturers, predictably, started designing their models glued to the 40 mm limit.
The honest conclusion
Calling it technological doping is imprecise. Doping involves circumventing a rule and hiding. Super shoes are legal, regulated and sold in any store. The benefit is measurable (near 4% in economy, something like 1% in time) and equal for whoever wants to wear them.
For those who run for pleasure or amateur performance, the lesson is sober: the super shoe can help, but the 1% to 2% gain applies to an already well-trained body. No foam replaces aerobic base, consistency and technique.
